EGFR and neoplasm: Using silicon phthalocyanine as the photosensitiser and EGFR inhibitors as the tumour-targeting component, Xue et al. created theranostic agents 10 (λmax-em = 680 nm) and 11 (λmax-em = 674 nm) [33,34].